These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34346755)

  • 1. COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study.
    Song Y; Ge Z; Cui S; Tian D; Wan G; Zhu S; Wang X; Wang Y; Zhao X; Xiang P; Xu Y; Zhang T; Liu L; Liu G; Wang Y; Tan J; Zhang W; Xu W; Chen Z
    Microbiol Spectr; 2021 Sep; 9(1):e0027321. PubMed ID: 34346755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo.
    Tani-Sassa C; Iwasaki Y; Ichimura N; Nagano K; Takatsuki Y; Yuasa S; Takahashi Y; Nakajima J; Sonobe K; Nukui Y; Takeuchi H; Tanimoto K; Tanaka Y; Kimura A; Tohda S
    J Med Virol; 2022 Apr; 94(4):1707-1710. PubMed ID: 34825717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.
    Ren GL; Wang XF; Xu J; Li J; Meng Q; Xie GQ; Huang B; Zhu WC; Lin J; Tang CH; Ye S; Li Z; Zhu J; Tang Z; Ma MX; Xie C; Wu YW; Liu CX; Yang F; Zhou YZ; Zheng Y; Lan SL; Chen JF; Ye F; He Y; Wu BQ; Chen L; Fu SM; Zheng CZ; Shi Y
    Mil Med Res; 2021 Feb; 8(1):13. PubMed ID: 33593415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survey on source of infection of the first local outbreak caused by SARS-CoV-2 Alpha variant in China].
    Wu SS; Ma CN; Zhang L; Duan W; Sun Y; Dou XF; Wang XL; Jia L; Yang P; Wang QY; Pang XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Nov; 55(11):1311-1315. PubMed ID: 34749474
    [No Abstract]   [Full Text] [Related]  

  • 5. Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance.
    Corchis-Scott R; Geng Q; Seth R; Ray R; Beg M; Biswas N; Charron L; Drouillard KD; D'Souza R; Heath DD; Houser C; Lawal F; McGinlay J; Menard SL; Porter LA; Rawlings D; Scholl ML; Siu KWM; Tong Y; Weisener CG; Wilhelm SW; McKay RML
    Microbiol Spectr; 2021 Oct; 9(2):e0079221. PubMed ID: 34612693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines.
    de Souza WM; Muraro SP; Souza GF; Amorim MR; Sesti-Costa R; Mofatto LS; Forato J; Barbosa PP; Toledo-Teixeira DA; Bispo-Dos-Santos K; Parise PL; Brunetti NS; Moreira JCO; Costa VA; Cardozo DM; Moretti ML; Barros-Mazon S; Marchesi GF; Ambrosio C; Spilki FR; Almeida VC; Vieira AS; Zambon L; Farias AS; Addas-Carvalho M; Benites BD; Marques RE; Sabino EC; Zuben ABV; Weaver SC; Faria NR; Granja F; Angerami RN; Proença-Módena JL
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological characteristics of local outbreak of COVID-19 caused by SARS-CoV-2 Delta variant in Liwan district, Guangzhou].
    Li WY; Du ZC; Wang Y; Lin X; Lu L; Fang Q; Zhang WF; Cai MW; Xu L; Hao YT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1763-1768. PubMed ID: 34814609
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.
    Dougherty K; Mannell M; Naqvi O; Matson D; Stone J
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(28):1004-1007. PubMed ID: 34264910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    ; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
    JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.
    Zelyas N; Pabbaraju K; Croxen MA; Lynch T; Buss E; Murphy SA; Shokoples S; Wong A; Kanji JN; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0031521. PubMed ID: 34378966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.
    Frampton D; Rampling T; Cross A; Bailey H; Heaney J; Byott M; Scott R; Sconza R; Price J; Margaritis M; Bergstrom M; Spyer MJ; Miralhes PB; Grant P; Kirk S; Valerio C; Mangera Z; Prabhahar T; Moreno-Cuesta J; Arulkumaran N; Singer M; Shin GY; Sanchez E; Paraskevopoulou SM; Pillay D; McKendry RA; Mirfenderesky M; Houlihan CF; Nastouli E
    Lancet Infect Dis; 2021 Sep; 21(9):1246-1256. PubMed ID: 33857406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical indexes of 11 COVID-19 patients and the genome sequence analysis of the tested SARS-CoV-2.
    Yu Z; Wu H; Huang Q; Zhong Z
    J Clin Lab Anal; 2021 Dec; 35(12):e24088. PubMed ID: 34741347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
    Fillâtre P; Dufour MJ; Behillil S; Vatan R; Reusse P; Gabellec A; Velmans N; Montagne C; Geffroy Du Coudret S; Droumaguet E; Merour V; Enouf V; Buzelé R; Valence M; Guillotel E; Gagnière B; Baidaliuk A; Zhukova A; Tourdjman M; Thibault V; Grolhier C; Pronier C; Lescure FX; Simon-Loriere E; Costagliola D; Van Der Werf S; Tattevin P; Massart N
    Clin Microbiol Infect; 2022 Feb; 28(2):298.e9-298.e15. PubMed ID: 34627988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China.
    Cheng Z; Lu Y; Cao Q; Qin L; Pan Z; Yan F; Yang W
    AJR Am J Roentgenol; 2020 Jul; 215(1):121-126. PubMed ID: 32174128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.